Adapting Proteostasis and Autophagy for Controlling the Pathogenesis of Cystic Fibrosis Lung Disease
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Adapting Proteostasis and Autophagy for Controlling the Pathogenesis of Cystic Fibrosis Lung Disease
Authors
Keywords
-
Journal
Frontiers in Pharmacology
Volume 10, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2019-02-01
DOI
10.3389/fphar.2019.00020
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cigarette smoke-induced autophagy impairment accelerates lung aging, COPD-emphysema exacerbations and pathogenesis
- (2018) Neeraj Vij et al. AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY
- Emerging novel drug delivery strategies for bioactive flavonol fisetin in biomedicine
- (2018) Piyush Mehta et al. BIOMEDICINE & PHARMACOTHERAPY
- The role of mTOR-mediated signaling in the regulation of cellular migration
- (2018) Ailsa K. Holroyd et al. IMMUNOLOGY LETTERS
- Cysteamine, an Endogenous Aminothiol, and Cystamine, the Disulfide Product of Oxidation, Increase Pseudomonas aeruginosa Sensitivity to Reactive Oxygen and Nitrogen Species and Potentiate Therapeutic Antibiotics against Bacterial Infection
- (2018) Douglas J. Fraser-Pitt et al. INFECTION AND IMMUNITY
- The Role of the Mammalian Target of Rapamycin (mTOR) in Pulmonary Fibrosis
- (2018) Jessica Lawrence et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Silencing of the Hsp70-specific nucleotide-exchange factor BAG3 corrects the F508del-CFTR variant by restoring autophagy
- (2018) Darren M. Hutt et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- R560S: A class II CFTR mutation that is not rescued by current modulators
- (2018) Nikhil T. Awatade et al. Journal of Cystic Fibrosis
- MTOR Suppresses Cigarette Smoke–Induced Epithelial Cell Death and Airway Inflammation in Chronic Obstructive Pulmonary Disease
- (2018) Yong Wang et al. JOURNAL OF IMMUNOLOGY
- F508del-CFTR is not corrected by thymosin α1
- (2018) Elizabeth Matthes et al. NATURE MEDICINE
- Cigarette Smoke-Induced Acquired Dysfunction of Cystic Fibrosis Transmembrane Conductance Regulator in the Pathogenesis of Chronic Obstructive Pulmonary Disease
- (2018) Juan Shi et al. Oxidative Medicine and Cellular Longevity
- Cystic fibrosis in the era of precision medicine
- (2018) Shruti M. Paranjape et al. Paediatric Respiratory Reviews
- Interplay Between the Autophagy-Lysosomal Pathway and the Ubiquitin-Proteasome System: A Target for Therapeutic Development in Alzheimer’s Disease
- (2018) Hianara A. Bustamante et al. Frontiers in Cellular Neuroscience
- Evaluation of autophagy inducers in epithelial cells carrying the ΔF508 mutation of the cystic fibrosis transmembrane conductance regulator CFTR
- (2018) Shaoyi Zhang et al. Cell Death & Disease
- Unmet needs in cystic fibrosis: the next steps in improving outcomes
- (2018) Natalie E. West et al. Expert Review of Respiratory Medicine
- “Immune TOR-opathies,” a Novel Disease Entity in Clinical Immunology
- (2018) Sophie Jung et al. Frontiers in Immunology
- mTOR at the Transmitting and Receiving Ends in Tumor Immunity
- (2018) Yakir Guri et al. Frontiers in Immunology
- mTOR Pathways in Cancer and Autophagy
- (2018) Mathieu Paquette et al. Cancers
- From thymus to cystic fibrosis: the amazing life of thymosin alpha 1
- (2018) Enrico Garaci EXPERT OPINION ON BIOLOGICAL THERAPY
- Cellular proteostasis: a new twist in the action of thymosin α1
- (2018) Claudia Stincardini et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Unmet needs in cystic fibrosis
- (2018) Bruce K. Rubin EXPERT OPINION ON BIOLOGICAL THERAPY
- Role of mTOR Signaling in Tumor Microenvironment: An Overview
- (2018) Fabiana Conciatori et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- The efficacy and adverse events of mTOR inhibitors in lymphangioleiomyomatosis: systematic review and meta-analysis
- (2018) Nannan Gao et al. Orphanet Journal of Rare Diseases
- A novel triple combination of pharmacological chaperones improves F508del-CFTR correction
- (2018) Graeme W. Carlile et al. Scientific Reports
- Tezacaftor for the treatment of cystic fibrosis
- (2018) Marc A. Sala et al. Expert Review of Respiratory Medicine
- Brain ageing and neurodegenerative disease: The role of cellular waste management
- (2018) Simona Daniele et al. BIOCHEMICAL PHARMACOLOGY
- VX-659–Tezacaftor–Ivacaftor in Patients with Cystic Fibrosis and One or Two Phe508del Alleles
- (2018) Jane C. Davies et al. NEW ENGLAND JOURNAL OF MEDICINE
- The Autophagy Inhibitor Spautin-1 Antagonizes Rescue of Mutant CFTR Through an Autophagy-Independent and USP13-Mediated Mechanism
- (2018) Emanuela Pesce et al. Frontiers in Pharmacology
- Autophagy augmentation alleviates cigarette smoke-induced CFTR-dysfunction, ceramide-accumulation and COPD-emphysema pathogenesis
- (2018) Manish Bodas et al. FREE RADICAL BIOLOGY AND MEDICINE
- mTORC1 as the main gateway to autophagy
- (2017) Yoana Rabanal-Ruiz et al. Essays in Biochemistry
- An update on new and emerging therapies for cystic fibrosis
- (2017) Kristin M. Hudock et al. EXPERT OPINION ON EMERGING DRUGS
- The HDAC inhibitor SAHA does not rescue CFTR membrane expression in Cystic Fibrosis
- (2017) Anne Bergougnoux et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Pathways of cellular proteostasis in aging and disease
- (2017) Courtney L. Klaips et al. JOURNAL OF CELL BIOLOGY
- Pharmacokinetics and safety of cavosonstat (N91115) in healthy and cystic fibrosis adults homozygous for F 508 DEL - CFTR
- (2017) Scott H. Donaldson et al. Journal of Cystic Fibrosis
- A Link Between a Common Mutation in CFTR and Impaired Innate and Adaptive Viral Defense
- (2017) Emma Svedin et al. JOURNAL OF INFECTIOUS DISEASES
- Cystic fibrosis: current therapeutic targets and future approaches
- (2017) Misbahuddin M. Rafeeq et al. Journal of Translational Medicine
- Cigarette Smoke Exposure Inhibits Bacterial Killing via TFEB-Mediated Autophagy Impairment and Resulting Phagocytosis Defect
- (2017) Garrett Pehote et al. MEDIATORS OF INFLAMMATION
- Thymosin α1 represents a potential potent single-molecule-based therapy for cystic fibrosis
- (2017) Luigina Romani et al. NATURE MEDICINE
- Dendrimer-based selective autophagy-induction rescues ΔF508-CFTR and inhibits Pseudomonas aeruginosa infection in cystic fibrosis
- (2017) Scott Mackenzie Brockman et al. PLoS One
- Cysteamine-mediated clearance of antibiotic-resistant pathogens in human cystic fibrosis macrophages
- (2017) Chandra L. Shrestha et al. PLoS One
- Cigarette smoke induced autophagy-impairment regulates AMD pathogenesis mechanisms in ARPE-19 cells
- (2017) Viren Kumar Govindaraju et al. PLoS One
- Lung function response and side effects to rapamycin for lymphangioleiomyomatosis: a prospective national cohort study
- (2017) Janet Bee et al. THORAX
- Cysteamine re-establishes the clearance of Pseudomonas aeruginosa by macrophages bearing the cystic fibrosis-relevant F508del-CFTR mutation
- (2017) Eleonora Ferrari et al. Cell Death & Disease
- Nanomedicine approaches for sirolimus delivery: a review of pharmaceutical properties and preclinical studies
- (2017) Azadeh Haeri et al. Artificial Cells Nanomedicine and Biotechnology
- Suberanilohydroxamic Acid as a Pharmacological Kruppel‐Like Factor 2 Activator That Represses Vascular Inflammation and Atherosclerosis
- (2017) Yanni Xu et al. Journal of the American Heart Association
- Lumacaftor/ivacaftor, a novel agent for the treatment of cystic fibrosis patients who are homozygous for the F580del CFTR mutation
- (2017) Marilyn N. Bulloch et al. Expert Review of Clinical Pharmacology
- Proteostasis, oxidative stress and aging
- (2017) Ioanna Korovila et al. Redox Biology
- Targeting the PI3K/Akt/mTOR signalling pathway in Cystic Fibrosis
- (2017) R. Reilly et al. Scientific Reports
- Augmentation of CFTR maturation by S-nitrosoglutathione reductase
- (2016) Khalequz Zaman et al. AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY
- Attenuation of airway smooth muscle contractility via flavonol-mediated inhibition of phospholipase-Cβ
- (2016) Amy Brown et al. AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY
- Elevated Mirc1/Mir17-92 cluster expression negatively regulates autophagy and CFTR (cystic fibrosis transmembrane conductance regulator) function in CF macrophages
- (2016) Mia F. Tazi et al. Autophagy
- A novel treatment of cystic fibrosis acting on-target: cysteamine plus epigallocatechin gallate for the autophagy-dependent rescue of class II-mutated CFTR
- (2016) A Tosco et al. CELL DEATH AND DIFFERENTIATION
- An Open-Label Investigation of the Pharmacokinetics and Tolerability of Oral Cysteamine in Adults with Cystic Fibrosis
- (2016) Graham Devereux et al. CLINICAL DRUG INVESTIGATION
- Proliferation, survival and metabolism: the role of PI3K/AKT/mTOR signalling in pluripotency and cell fate determination
- (2016) Jason S. L. Yu et al. DEVELOPMENT
- Synthesis of diacylated γ-glutamyl-cysteamine prodrugs, and in vitro evaluation of their cytotoxicity and intracellular delivery of cysteamine
- (2016) Lisa Frost et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Nano-based rescue of dysfunctional autophagy in chronic obstructive lung diseases
- (2016) Neeraj Vij Expert Opinion on Drug Delivery
- To eat, or NOt to eat:S-nitrosylation signaling in autophagy
- (2016) Costanza Montagna et al. FEBS Journal
- Nicotine exposure induces bronchial epithelial cell apoptosis and senescence via ROS mediated autophagy-impairment
- (2016) Manish Bodas et al. FREE RADICAL BIOLOGY AND MEDICINE
- Fatty Acid Cysteamine Conjugates as Novel and Potent Autophagy Activators That Enhance the Correction of Misfolded F508del-Cystic Fibrosis Transmembrane Conductance Regulator (CFTR)
- (2016) Chi B. Vu et al. JOURNAL OF MEDICINAL CHEMISTRY
- Design, Synthesis, and Biological Evaluation of First-in-Class Dual Acting Histone Deacetylases (HDACs) and Phosphodiesterase 5 (PDE5) Inhibitors for the Treatment of Alzheimer’s Disease
- (2016) Obdulia Rabal et al. JOURNAL OF MEDICINAL CHEMISTRY
- Rapamycin: An InhibiTOR of Aging Emerges From the Soil of Easter Island
- (2016) Sebastian I. Arriola Apelo et al. JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES
- Inhibition of the Mechanistic Target of Rapamycin (mTOR)–Rapamycin and Beyond
- (2016) Dudley W. Lamming Cold Spring Harbor Perspectives in Medicine
- HDAC Inhibitors as Epigenetic Regulators of the Immune System: Impacts on Cancer Therapy and Inflammatory Diseases
- (2016) Elizabeth E. Hull et al. Biomed Research International
- Cystinosis: a new perspective
- (2016) Koenraad R. P. Veys et al. ACTA CLINICA BELGICA
- CFTR Modulators: Shedding Light on Precision Medicine for Cystic Fibrosis
- (2016) Miquéias Lopes-Pacheco Frontiers in Pharmacology
- Role of Cigarette Smoke–Induced Aggresome Formation in Chronic Obstructive Pulmonary Disease–Emphysema Pathogenesis
- (2015) Ian Tran et al. AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY
- Fisetin Alleviates Lipopolysaccharide-Induced Acute Lung Injury via TLR4-Mediated NF-κB Signaling Pathway in Rats
- (2015) Guang Feng et al. INFLAMMATION
- Enhancing Autophagy with Drugs or Lung-directed Gene Therapy Reverses the Pathological Effects of Respiratory Epithelial Cell Proteinopathy
- (2015) Tunda Hidvegi et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- HDAC inhibitor–dependent transcriptome and memory reinstatement in cognitive decline models
- (2015) Eva Benito et al. JOURNAL OF CLINICAL INVESTIGATION
- mTOR: a pharmacologic target for autophagy regulation
- (2015) Young Chul Kim et al. JOURNAL OF CLINICAL INVESTIGATION
- Inflammation in cystic fibrosis lung disease: Pathogenesis and therapy
- (2015) André M. Cantin et al. Journal of Cystic Fibrosis
- Origins of Cystic Fibrosis Lung Disease
- (2015) David A. Stoltz et al. NEW ENGLAND JOURNAL OF MEDICINE
- Lumacaftor–Ivacaftor in Patients with Cystic Fibrosis Homozygous for Phe508del CFTR
- (2015) NEW ENGLAND JOURNAL OF MEDICINE
- HDAC Inhibitors as Novel Anti-Cancer Therapeutics
- (2015) Cristabelle Souza et al. Recent Patents on Anti-Cancer Drug Discovery
- Treatment of chronic kidney diseases with histone deacetylase inhibitors
- (2015) Na Liu et al. Frontiers in Physiology
- Vorinostat-An overview
- (2015) AdityaKumar Bubna INDIAN JOURNAL OF DERMATOLOGY
- Cysteamine as a Future Intervention in Cystic Fibrosis Against Current and Emerging Pathogens: A Patient-based ex vivo Study Confirming its Antimicrobial and Mucoactive Potential in Sputum
- (2015) Graham Devereux et al. EBioMedicine
- Review article: selective histone deacetylase isoforms as potential therapeutic targets in inflammatory bowel diseases
- (2014) C. Felice et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- The emerging potential of autophagy-based therapies in the treatment of cystic fibrosis lung infections
- (2014) Robert D Junkins et al. Autophagy
- Restoration of CFTR function in patients with cystic fibrosis carrying the F508del-CFTR mutation
- (2014) Daniela De Stefano et al. Autophagy
- S-nitrosothiols increases cystic fibrosis transmembrane regulator expression and maturation in the cell surface
- (2014) Khalequz Zaman et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Rapamycin: One Drug, Many Effects
- (2014) Jing Li et al. Cell Metabolism
- The role of PI3K/AKT/mTOR pathway in the modulation of autophagy and the clearance of protein aggregates in neurodegeneration
- (2014) David Heras-Sandoval et al. CELLULAR SIGNALLING
- Medical nanoparticles for next generation drug delivery to the lungs
- (2014) S. H. van Rijt et al. EUROPEAN RESPIRATORY JOURNAL
- Combining Valosin-containing Protein (VCP) Inhibition and Suberanilohydroxamic Acid (SAHA) Treatment Additively Enhances the Folding, Trafficking, and Function of Epilepsy-associated γ-Aminobutyric Acid, Type A (GABAA) Receptors
- (2014) Dong-Yun Han et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- New and emerging HDAC inhibitors for cancer treatment
- (2014) Alison C. West et al. JOURNAL OF CLINICAL INVESTIGATION
- Histone deacetylases and their inhibitors in cancer, neurological diseases and immune disorders
- (2014) Katrina J. Falkenberg et al. NATURE REVIEWS DRUG DISCOVERY
- Cysteamine (Lynovex®), a novel mucoactive antimicrobial & antibiofilm agent for the treatment of cystic fibrosis
- (2014) Cedric Charrier et al. Orphanet Journal of Rare Diseases
- Development of Vorinostat-Loaded Solid Lipid Nanoparticles to Enhance Pharmacokinetics and Efficacy against Multidrug-Resistant Cancer Cells
- (2014) Tuan Hiep Tran et al. PHARMACEUTICAL RESEARCH
- Pharmacologic inhibition of S-nitrosoglutathione reductase protects against experimental asthma in BALB/c mice through attenuation of both bronchoconstriction and inflammation
- (2014) Joan P Blonder et al. BMC Pulmonary Medicine
- Application and interpretation of current autophagy inhibitors and activators
- (2013) Ya-ping Yang et al. ACTA PHARMACOLOGICA SINICA
- Towards a rational combination therapy of cystic fibrosis
- (2013) Valeria R. Villella et al. Autophagy
- Correctors of the basic trafficking defect of the mutant F508del-CFTR that causes cystic fibrosis
- (2013) Véronique Birault et al. CURRENT OPINION IN CHEMICAL BIOLOGY
- Cysteamine: an old drug with new potential
- (2013) Martine Besouw et al. DRUG DISCOVERY TODAY
- Fisetin-loaded nanocochleates: formulation, characterisation,in vitroanticancer testing, bioavailability and biodistribution study
- (2013) Chellampillai Bothiraja et al. Expert Opinion on Drug Delivery
- Liposomal encapsulation of the natural flavonoid fisetin improves bioavailability and antitumor efficacy
- (2013) Johanne Seguin et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Vorinostat plus tacrolimus and mycophenolate to prevent graft-versus-host disease after related-donor reduced-intensity conditioning allogeneic haemopoietic stem-cell transplantation: a phase 1/2 trial
- (2013) Sung Won Choi et al. LANCET ONCOLOGY
- Targeting the Intracellular Environment in Cystic Fibrosis: Restoring Autophagy as a Novel Strategy to Circumvent the CFTR Defect
- (2013) Valeria Rachela Villella et al. Frontiers in Pharmacology
- Fisetin: A Dietary Antioxidant for Health Promotion
- (2012) Naghma Khan et al. ANTIOXIDANTS & REDOX SIGNALING
- Dietary flavonoid fisetin: A novel dual inhibitor of PI3K/Akt and mTOR for prostate cancer management
- (2012) Vaqar Mustafa Adhami et al. BIOCHEMICAL PHARMACOLOGY
- Can Correcting the ΔF508-CFTR Proteostasis-Defect Rescue CF Lung Disease?
- (2012) C. W. Valle et al. CURRENT MOLECULAR MEDICINE
- Therapeutic Strategies to Correct Proteostasis-Imbalance in Chronic Obstructive Lung Diseases
- (2012) M. Bodas et al. CURRENT MOLECULAR MEDICINE
- Fisetin, a bioactive flavonol, attenuates allergic airway inflammation through negative regulation of NF-κB
- (2012) Fera Y. Goh et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Nanoemulsion formulation of fisetin improves bioavailability and antitumour activity in mice
- (2012) Héloïse Ragelle et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Histone Deacetylase Inhibitor (HDACi) Suberoylanilide Hydroxamic Acid (SAHA)-mediated Correction of α1-Antitrypsin Deficiency
- (2012) Marion Bouchecareilh et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Depletion of the Ubiquitin-binding Adaptor Molecule SQSTM1/p62 from Macrophages HarboringcftrΔF508 Mutation Improves the Delivery ofBurkholderia cenocepaciato the Autophagic Machinery
- (2012) Basant A. Abdulrahman et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Vorinostat with sustained exposure and high solubility in poly(ethylene glycol)‐b‐poly(dl‐lactic acid) micelle nanocarriers: Characterization and effects on pharmacokinetics in rat serum and urine
- (2012) Elham A. Mohamed et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- Rescue of the mutant CFTR chloride channel by pharmacological correctors and low temperature analyzed by gene expression profiling
- (2011) Elvira Sondo et al. AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY
- Autophagy stimulation by rapamycin suppresses lung inflammation and infection byBurkholderia cenocepaciain a model of cystic fibrosis
- (2011) Basant A. Abdulrahman et al. Autophagy
- Nano-based theranostics for chronic obstructive lung diseases: challenges and therapeutic potential
- (2011) Neeraj Vij Expert Opinion on Drug Delivery
- Enhanced bioavailability of sirolimus via preparation of solid dispersion nanoparticles using a supercritical antisolvent process
- (2011) Sung-Joo Hwang et al. International Journal of Nanomedicine
- S-Nitrosoglutathione reduces oxidative injury and promotes mechanisms of neurorepair following traumatic brain injury in rats
- (2011) Mushfiquddin Khan et al. Journal of Neuroinflammation
- Cysteamine therapy: a treatment for cystinosis, not a cure
- (2011) Stephanie Cherqui KIDNEY INTERNATIONAL
- Correction of the F508del-CFTR protein processing defect in vitro by the investigational drug VX-809
- (2011) F. Van Goor et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- CFTR: folding, misfolding and correcting the ΔF508 conformational defect
- (2011) Gergely L. Lukacs et al. TRENDS IN MOLECULAR MEDICINE
- Potential Agents for Treating Cystic Fibrosis: Cyclic Tetrapeptides That Restore Trafficking and Activity of ΔF508-CFTR
- (2011) Darren M. Hutt et al. ACS Medicinal Chemistry Letters
- Discovery of S-Nitrosoglutathione Reductase Inhibitors: Potential Agents for the Treatment of Asthma and Other Inflammatory Diseases
- (2011) Xicheng Sun et al. ACS Medicinal Chemistry Letters
- Cystic fibrosis: A disorder with defective autophagy
- (2010) Alessandro Luciani et al. Autophagy
- Rescue of F508del-CFTR by RXR motif inactivation triggers proteome modulation associated with the unfolded protein response
- (2010) Patrícia Gomes-Alves et al. BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS
- Defective CFTR induces aggresome formation and lung inflammation in cystic fibrosis through ROS-mediated autophagy inhibition
- (2010) Alessandro Luciani et al. NATURE CELL BIOLOGY
- Effect of VX-770 in Persons with Cystic Fibrosis and the G551D-CFTRMutation
- (2010) Frank J. Accurso et al. NEW ENGLAND JOURNAL OF MEDICINE
- Hsp 70/Hsp 90 organizing protein as a nitrosylation target in cystic fibrosis therapy
- (2010) N. V. Marozkina et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Development of PEGylated PLGA nanoparticle for controlled and sustained drug delivery in cystic fibrosis
- (2010) Neeraj Vij et al. JOURNAL OF NANOBIOTECHNOLOGY
- S-Nitrosoglutathione Reductase
- (2009) Loretta G. Que et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Reduced histone deacetylase 7 activity restores function to misfolded CFTR in cystic fibrosis
- (2009) Darren M Hutt et al. Nature Chemical Biology
- CFTR Is a Negative Regulator of NFκB Mediated Innate Immune Response
- (2009) Neeraj Vij et al. PLoS One
- Cystic Fibrosis Transmembrane Regulator Missing the First Four Transmembrane Segments Increases Wild Type and ΔF508 Processing
- (2008) Liudmila Cebotaru et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Ceramide accumulation mediates inflammation, cell death and infection susceptibility in cystic fibrosis
- (2008) Volker Teichgräber et al. NATURE MEDICINE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now